Tags

Type your tag names separated by a space and hit enter

[Place of gastroepiploic and epigastric arteries in myocardial revascularization].
Ann Chir. 1993; 47(9):860-3.AC

Abstract

Seventy patients underwent coronary artery bypass grafting with the right gastroepiploic artery or the inferior epigastric artery between 1989 and 1992 at the Montreal Heart Institute. There were 68 men and 2 women with a mean age of 53 +/- 8 years, the right gastroepiploic artery in situ was anastomosed to the right coronary artery in 55 patients and the inferior epigastric artery (free graft) was used in 18 patients. Double internal thoracic artery grafts were used in all patients. Early patency rate of right gastroepiploic artery and inferior epigastric artery grafts was 91% (31/34 grafts) and 57% (8/14 grafts) respectively. One patient died after surgery (1.4%) from acute renal failure and one patient developed an acute myocardial infarction (1.4%) at surgery. Fifty-five patients (55/57, 96%) showed no evidence of angina at the last follow-up. In conclusion, patency rate and clinical results of coronary artery bypass grafting with the right gastroepiploic artery graft were excellent and patency rate of inferior epigastric artery graft was unsatisfactory. We suggest that epigastric artery grafts should be used with caution, only when no other alternative is available.

Authors+Show Affiliations

Département de Chirurgie, Institut de Cardiologie de Montréal, Québec, Canada.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

English Abstract
Journal Article

Language

fre

PubMed ID

8141552

Citation

Perrault, L P., et al. "[Place of Gastroepiploic and Epigastric Arteries in Myocardial Revascularization]." Annales De Chirurgie, vol. 47, no. 9, 1993, pp. 860-3.
Perrault LP, Carrier M, Cartier R, et al. [Place of gastroepiploic and epigastric arteries in myocardial revascularization]. Ann Chir. 1993;47(9):860-3.
Perrault, L. P., Carrier, M., Cartier, R., Hudon, G., & Pelletier, L. C. (1993). [Place of gastroepiploic and epigastric arteries in myocardial revascularization]. Annales De Chirurgie, 47(9), 860-3.
Perrault LP, et al. [Place of Gastroepiploic and Epigastric Arteries in Myocardial Revascularization]. Ann Chir. 1993;47(9):860-3. PubMed PMID: 8141552.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Place of gastroepiploic and epigastric arteries in myocardial revascularization]. AU - Perrault,L P, AU - Carrier,M, AU - Cartier,R, AU - Hudon,G, AU - Pelletier,L C, PY - 1993/1/1/pubmed PY - 1993/1/1/medline PY - 1993/1/1/entrez SP - 860 EP - 3 JF - Annales de chirurgie JO - Ann Chir VL - 47 IS - 9 N2 - Seventy patients underwent coronary artery bypass grafting with the right gastroepiploic artery or the inferior epigastric artery between 1989 and 1992 at the Montreal Heart Institute. There were 68 men and 2 women with a mean age of 53 +/- 8 years, the right gastroepiploic artery in situ was anastomosed to the right coronary artery in 55 patients and the inferior epigastric artery (free graft) was used in 18 patients. Double internal thoracic artery grafts were used in all patients. Early patency rate of right gastroepiploic artery and inferior epigastric artery grafts was 91% (31/34 grafts) and 57% (8/14 grafts) respectively. One patient died after surgery (1.4%) from acute renal failure and one patient developed an acute myocardial infarction (1.4%) at surgery. Fifty-five patients (55/57, 96%) showed no evidence of angina at the last follow-up. In conclusion, patency rate and clinical results of coronary artery bypass grafting with the right gastroepiploic artery graft were excellent and patency rate of inferior epigastric artery graft was unsatisfactory. We suggest that epigastric artery grafts should be used with caution, only when no other alternative is available. SN - 0003-3944 UR - https://www.unboundmedicine.com/medline/citation/8141552/[Place_of_gastroepiploic_and_epigastric_arteries_in_myocardial_revascularization]_ DB - PRIME DP - Unbound Medicine ER -